HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norsolorinic acid inhibits proliferation of T24 human bladder cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas/membrane-bound Fas ligand-mediated apoptotic pathway.

Abstract
1. Norsolorinic acid, isolated from Aspergillus nidulans, has been shown to have antiproliferative activity in T24 human bladder cancer cells by arresting the cell cycle at the G(0)/G(1) phase and inducing apoptosis. The aim of the present study was to investigate the antiproliferative activity of norsolorinic acid in T24 human bladder cancer cells. 2. The effects of norsolorinic acid (1, 5, 10 and 20 micromol/L) on the proliferation of T24 cells and on the distribution of cells within different phases of the cell cycle were investigated indirectly using an XTT assay and a flow cytometer, respectively. Factors affecting the cell cycle and apoptosis, including p53, p21, Fas receptor, Fas ligand (FasL) and caspase 8 activity, were examined using ELISA. 3. The results showed that norsolorinic acid inhibited proliferation of T24 cells in a dose-dependent manner, with an IC(50) of 10.5 micromol/L. The effect involved the induction of cell cycle arrest at the G(0)/G(1) phase and apoptosis. 4. These results demonstrate that G(0)/G(1) phase arrest is due to increased expression of p21 in cells treated with norsolorinic acid (10 and 20 micromol/L) for 24 h. Moreover, enhanced Fas and membrane-bound Fas ligand (mFasL) may be responsible for the apoptotic effect of norsolorinic acid. Thus, the present study reports, for the first time, that induction of p21 and the Fas/mFas ligand apoptotic system may participate in the antiproliferative action of norsolorinic acid in T24 human bladder cancer cells.
AuthorsClay C C Wang, Yi-Ming Chiang, Po-Lin Kuo, Jiunn-Kae Chang, Ya-Ling Hsu
JournalClinical and experimental pharmacology & physiology (Clin Exp Pharmacol Physiol) Vol. 35 Issue 11 Pg. 1301-8 (Nov 2008) ISSN: 1440-1681 [Electronic] Australia
PMID18671724 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Anthraquinones
  • Fas Ligand Protein
  • Growth Inhibitors
  • Membrane Proteins
  • fas Receptor
  • norsolorinic acid
Topics
  • Anthraquinones (pharmacology, therapeutic use)
  • Apoptosis (drug effects, physiology)
  • Cell Line, Tumor
  • Cell Membrane (metabolism, physiology)
  • Cell Proliferation (drug effects)
  • Fas Ligand Protein (metabolism, physiology)
  • G1 Phase (drug effects, physiology)
  • Growth Inhibitors (pharmacology, therapeutic use)
  • Humans
  • Membrane Proteins (metabolism, physiology)
  • Protein Binding (drug effects, physiology)
  • Resting Phase, Cell Cycle (drug effects, physiology)
  • Signal Transduction (drug effects, physiology)
  • Urinary Bladder Neoplasms (pathology, prevention & control)
  • fas Receptor (metabolism, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: